Assessing the Impact of Therapeutic Advances in SCLC

(1:24:26)

Current controversies in Small Cell Lung Cancer (SCLC)

(20:17)

SCLC: Therapeutic progress or mirage?

(17:10)

SCLC: Therapeutic progress or mirage?

(19:28)

Small Cell Lung Cancer: Discovering New Metabolic Pathways

(2:41)

SCLC Therapy: First-line Options Prior to Immunotherapy

(5:57)

Frontline Therapy Approaches for Small Cell Lung Cancer

(4:37)

Facilitating Progress in the Treatment of SCLC

(51:59)

Innovations in Immunotherapy: Advancing care in SCLC

(1:48:29)

The current treatment landscape for SCLC

(2:53)

Treatment Approach in Limited- and Extensive-Stage SCLC

(4:23)

The potential of targeted and immune therapies in SCLC

(55)

Is there a place for maintenance therapy in extensive stage SCLC?

(4:8)

Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC)

(3:30)

Evaluating the role of systemic therapies in SCLC

(1:2)

Targeted Therapy in Non-Small Cell Lung Cancer

(5:53)

Addressing the Aggressive Nature of SCLC

(3:45)

Lindy’s Experience with Small Cell Lung Cancer

(2:40)

Current Controversies in Small Cell Lung Cancer (SCLC)

(20:17)

Exploring the latest advances in first-line treatment of ES-SCLC

(35:5)